Wed, April 24, 2024
Tue, April 23, 2024
Mon, April 22, 2024
Fri, April 19, 2024

Matt Miksic Maintained (ABT) at Buy with Decreased Target to $140 on, Apr 22nd, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-140-on-apr-22nd-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matt Miksic of Barclays, Maintained "Abbott Laboratories" (ABT) at Buy with Decreased Target from $141 to $140 on, Apr 22nd, 2024.

Matt has made no other calls on ABT in the last 4 months.



There are 4 other peers that have a rating on ABT. Out of the 4 peers that are also analyzing ABT, 0 agree with Matt's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Matt


  • Shagun Singh of "RBC Capital" Maintained at Buy with Decreased Target to $125 on, Thursday, April 18th, 2024
  • Vijay Kumar of "Evercore ISI Group" Maintained at Buy with Increased Target to $125 on, Thursday, April 4th, 2024
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $128 on, Wednesday, April 3rd, 2024
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $127 on, Thursday, January 25th, 2024

Publication Contributing Sources